Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
Go back to Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment| Uni-Pixel, Inc. (NASDAQ: NXL) | Delayed: 0.43 -0.04 (8.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $0.68 | |||
| Open | $0.47 | 52 Week Low | $0.62 | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $0.00 | |||
| Volume | 89,904 | |||||

